Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for healthcare industry professionals · Monday, February 24, 2020 · 510,470,797 Articles · 3+ Million Readers

Antibiotics Market to hit $40.78 Billion by 2025 - Global Insights on Top Trends, Growth Drivers, Competitive Landscape, Regulatory Scenario and Business Opportunities: Adroit Market Research

Global Antibiotics Market expected to grow at a CAGR of 4.4% during forecast period. In 2018 North America held the largest market share, however Asia Pacific is set to grow at a highest pace with a CAGR of 5.5%.

/EIN News/ -- Dallas, Texas, Jan. 18, 2020 (GLOBE NEWSWIRE) -- The “Global Antibiotics Market Size 2018, By Drug Class (Broad spectrum penicillins, Cephalosporins, Macrolides, Quinolones, Tetracyclines, Narrow spectrum penicillins, Trimethoprim & combinations, Others), By Route of Administration, (Oral, Parenteral) By Region and Forecast 2019 to 2025” study provides an elaborative view of historic, present and forecasted market estimates.

Adroit Market Research report on global antibiotics market gives a quantitative narration of the market demand, trends, drivers, restraints and opportunities spanning from 2015 to 2025. Historic trends have been studied from 2015 to 2017, with 2018 the base year of estimation and forecast from 2019-2025. The report contains the present status and future prospects of the market at global as well as country level. Additionally, the market has been assessed based on Porter's five forces analysis, along with the depiction of the industry’s value chain. The global antibiotics market is classified based on drug class and route of drug administration. Moreover, the report offers in-depth assessment of the market competitors along with company profiles of major players serving in the global market.

Request a pdf sample @

The global antibiotics market is expected to reach USD 40.78 billion by 2025. Increasing prevalence of infectious diseases worldwide is a major factor driving the global antibiotics market. Since the discovery of antibiotics in the early 20th century, these have been an essential tool in treating the massive burden of infectious diseases worldwide. Yet antimicrobial resistance or AMR is increasingly threatening the effectiveness of antibiotics, which may restrain their use.

The global antibiotics market has been segmented into drug class and route of drug administration. Drug class wise the market is broken down into broad spectrum penicillins, cephalosporins, macrolides, quinolones, tetracyclines, narrow spectrum penicillins, trimethoprim & combinations and others. Broad spectrum penicillins is project to be the largest segment through 2025 growing with a CAGR of 5.1%. Its ability to fight wide range of infections is expected to fuel its growth. In the route of administration segment the market has been bifurcated into oral and parenteral routes. The oral route of drug administration is estimated to be the largest segment by 2025.

Browse the complete report with Table of Contents and List of Figures @

Major players in the global antibiotics market are Abbott Laboratories, Merck & Co. Inc., GlaxoSmithKline Plc, F.Hoffmann-La Roche Ltd., Mylan N.V., Sanofi, Pfizer Inc., Novartis International AG, and Cipla Ltd among others.

North America is expected to dominate the global antibiotics market in 2025 with 34% market share, however, Asia Pacific will grow with a highest CAGR of 5.5% through the forecast period. Many low and middle income countries face both antibiotics excess and access issues. A 2015 study by the Centers for Disease Dynamics and Control found that global antibiotic consumption had increased by 65% in the past 15 years (from 21.1 billion to 34.8 billion defined daily doses). This was driven by rising consumption in low and middle income countries. In India, for example, easy access to the strongest antibiotics is a commonplace. In 2015, antibiotic consumption in India reached 4,950 defined daily doses per 1,000 people, up from 2,645 in 2000. Nevertheless, the burden of infectious diseases in India remains extremely high. Lower respiratory infections, diarrhoeal diseases and tuberculosis are among the ten deadliest diseases in India. Out of every 100,000 children aged under five in 2016, 258 died due to pneumonia, diarrhoea or another common infectious disease. Although infectious disease burdens are also linked to safe water, hygiene and sanitation, these numbers also indicate a clear unmet need for access to appropriate antibiotics.

Direct purchase the single user copy of the report @

Major points from Table of Contents:
1.  Introduction
2.  Research Methodology
3.  Market Outlook
4.   Antibiotics Market by Drug Class, 2015-2025 (USD Billion)
5.  Antibiotics Market by Route of Administration, 2015-2025 (USD Billion)
6.  Antibiotics Market by Region 2015-2025 (USD Billion)
7.  Competitive Landscape
8.  Company Profiles
9.  Appendix

Access research repository of Upcoming Reports @  

About Us:
Adroit Market Research is a global business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Contact Us:
                    Ryan Johnson
                    Account Manager - Global
                    3131 McKinney Ave Ste 600
                    Dallas, TX 75204
                    Email ID: 
                    Phone No.: +1 972-362 -8199
                    Connect with us: Facebook | Twitter | LinkedIn

Primary Logo

Powered by EIN News

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release